U.S. Markets closed

AstraZeneca’s 1Q18 Estimates: Segment-by-Segment Revenues

Mike Benson
AstraZeneca’s 1Q18 Estimates: Segment-by-Segment Revenues

As we discussed in the previous article, AstraZeneca’s (AZN) revenue is expected to report a 2.3% fall to $5.3 billion in 1Q18 compared to $5.4 billion in 1Q17.